North America Cancer Immunotherapy Market Size to register a growth of 13.1% CAGR

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report North America Cancer Immunotherapy Market, published by KBV research, the North America Cancer Immunotherapy Market would witness market growth of 13.1% CAGR during the forecast period (2018 – 2024).

The US market would dominate the North America Cytokines & Immunomodulators Cancer Immunotherapy Market by 2024; growing at a CAGR of 10.6 % during the forecast period. The Canada market is expected to witness a CAGR of 13.2% during (2018 - 2024). Additionally, The Mexico market is expected to witness a CAGR of 12.5% during (2018 - 2024).

The Hospitals market dominated the North America Cancer Immunotherapy Market by End User 2017, thereby, achieving a market value of $25,898.6 million by 2024The Clinics market is expected to witness a CAGR of 12.7% during (2018 - 2024). Additionally, The Other End User market is expected to witness highest CAGR of 13.4% during (2018 - 2024).

The Monoclonal Antibodies market dominated the Mexico Cancer Immunotherapy Market by Technology 2017, growing at a CAGR of 14.5 % during the forecast period. The Cytokines & Immunomodulators market is expected to witness a CAGR of 12.5% during (2018 - 2024). Additionally, The Other Technology market is expected to witness highest CAGR of 14.8% during (2018 - 2024).

Full Report: https://www.kbvresearch.com/north-america-cancer-immunotherapy-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of AstraZeneca, Amgen Inc., Eli Lilly and Company, Merck & Co., Inc., Bristol-Myers Squibb Company, Pfizer Inc., Bayer Ag, Immunomedics Inc., Novartis AG, F. Hoffmann-La Roche Ltd

North America Cancer Immunotherapy Market Segmentation

By Technology

  • Monoclonal Antibodies,
  • Cytokines & Immunomodulators
  • Other technology

By Application

  •  Lung cancer
  •  Breast cancer
  • Colorectal
  •  Prostate cancer
  • Head & Neck cancer
  • Other application.

By End User

  • Hospitals
  • Clinics
  • Other End User

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Companies Profiled

  • AstraZeneca
  • Amgen Inc.
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Bristol-Myers Squibb Company
  • Pfizer Inc.
  • Bayer Ag
  • Immunomedics Inc.
  • Novartis AG
  • F. Hoffmann-La Roche Ltd

Unique Offerings from KBV Research

  • Exhaustive coverage  
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Cancer Immunotherapy Market (2018-2024)

Europe Cancer Immunotherapy Market (2018-2024)

Asia Pacific Cancer Immunotherapy Market (2018-2024)

LAMEA Cancer Immunotherapy Market (2018-2024)

Request For Sample


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.